Steve Y. Cho

5.3k total citations · 3 hit papers
89 papers, 3.5k citations indexed

About

Steve Y. Cho is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Steve Y. Cho has authored 89 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Pulmonary and Respiratory Medicine, 47 papers in Radiology, Nuclear Medicine and Imaging and 22 papers in Oncology. Recurrent topics in Steve Y. Cho's work include Prostate Cancer Treatment and Research (31 papers), Medical Imaging Techniques and Applications (24 papers) and Radiopharmaceutical Chemistry and Applications (22 papers). Steve Y. Cho is often cited by papers focused on Prostate Cancer Treatment and Research (31 papers), Medical Imaging Techniques and Applications (24 papers) and Radiopharmaceutical Chemistry and Applications (22 papers). Steve Y. Cho collaborates with scholars based in United States, Canada and South Korea. Steve Y. Cho's co-authors include Hyung‐Jun Im, Steven P. Rowe, Martin G. Pomper, Zsolt Szabó, Tyler Bradshaw, Robert F. Dannals, Ronnie C. Mease, Weibo Cai, Emmanuel S. Antonarakis and Meiyappan Solaiyappan and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Steve Y. Cho

86 papers receiving 3.4k citations

Hit Papers

DNA origami nanostructures can exhibit preferential renal... 2015 2026 2018 2022 2018 2015 2021 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. DNA origami nanostructures can exhibit preferential renal uptake and alleviate acute kidney injury
    2018 359 citations Dawei Jiang, Hyung‐Jun Im et al. profile →
  2. Initial Evaluation of [18F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer
    2015 354 citations Zsolt Szabó, Esther Mena et al. Molecular Imaging and Biology profile →
  3. Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study
    2021 237 citations Michael J. Morris, Steven P. Rowe et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steve Y. Cho United States 27 1.6k 1.6k 756 645 423 89 3.5k
June-Key Chung South Korea 37 1.1k 0.6× 2.1k 1.3× 744 1.0× 846 1.3× 339 0.8× 152 4.4k
Andrei Iagaru United States 41 2.1k 1.3× 2.9k 1.8× 1.3k 1.8× 439 0.7× 397 0.9× 253 5.0k
Katherine A. Vallis United Kingdom 40 1.0k 0.6× 1.8k 1.1× 1.4k 1.9× 1.4k 2.2× 607 1.4× 154 4.6k
Carsten Herskind Germany 31 1.1k 0.7× 985 0.6× 663 0.9× 787 1.2× 268 0.6× 123 3.1k
Jeffrey Y.C. Wong United States 43 1.8k 1.1× 2.7k 1.6× 1.5k 2.0× 934 1.4× 319 0.8× 214 5.4k
James M. Larner United States 38 1.8k 1.1× 851 0.5× 943 1.2× 1.1k 1.8× 359 0.8× 151 4.3k
Margret Schottelius Germany 44 2.5k 1.6× 3.8k 2.3× 2.4k 3.2× 1.1k 1.7× 323 0.8× 114 6.1k
Gerard W.M. Visser Netherlands 34 1.4k 0.8× 2.6k 1.6× 1.1k 1.4× 724 1.1× 680 1.6× 80 4.1k
Alan B. Packard United States 26 449 0.3× 1.1k 0.7× 538 0.7× 679 1.1× 233 0.6× 85 2.6k
Tatsuo Ohira Japan 35 2.2k 1.3× 506 0.3× 948 1.3× 879 1.4× 412 1.0× 149 3.4k

Countries citing papers authored by Steve Y. Cho

Since Specialization
Citations

This map shows the geographic impact of Steve Y. Cho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Y. Cho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Y. Cho more than expected).

Fields of papers citing papers by Steve Y. Cho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Y. Cho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Y. Cho. The network helps show where Steve Y. Cho may publish in the future.

Co-authorship network of co-authors of Steve Y. Cho

This figure shows the co-authorship network connecting the top 25 collaborators of Steve Y. Cho. A scholar is included among the top collaborators of Steve Y. Cho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve Y. Cho. Steve Y. Cho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morris, Zachary S., et al.. (2024). A phase I/IIa of [212Pb]VMT01 targeted a-particle therapy for unresectable or metastatic melanoma.. Journal of Clinical Oncology. 42(16_suppl). TPS9610–TPS9610. 4 indexed citations
2.
Yousefirizi, Fereshteh, Ivan S. Klyuzhin, Joo Hyun O, et al.. (2024). TMTV-Net: fully automated total metabolic tumor volume segmentation in lymphoma PET/CT images — a multi-center generalizability analysis. European Journal of Nuclear Medicine and Molecular Imaging. 51(7). 1937–1954. 20 indexed citations
3.
Lo, Andrea, Inki Lee, Qinglin Pei, et al.. (2023). Prognostic value of chest x‐ray‐ and CT‐defined large mediastinal adenopathy in high‐risk pediatric Hodgkin lymphoma: A report from the Children's Oncology Group Study AHOD0831. Pediatric Blood & Cancer. 70(8). e30452–e30452. 2 indexed citations
4.
Lee, Changhee, et al.. (2023). Domain-adapted Large Language Models for Classifying Nuclear Medicine Reports. Radiology Artificial Intelligence. 5(6). e220281–e220281. 16 indexed citations
5.
Sadowski, Elizabeth A., et al.. (2023). Distribution of prostate specific membrane antigen (PSMA) on PET-MRI in patients with and without ovarian cancer. Abdominal Radiology. 48(12). 3643–3652. 3 indexed citations
6.
Floberg, John M., Shane A. Wells, R. A. Bayliss, et al.. (2023). Using 18F-DCFPyL Prostate-Specific Membrane Antigen–Directed Positron Emission Tomography/Magnetic Resonance Imaging to Define Intraprostatic Boosts for Prostate Stereotactic Body Radiation Therapy. Advances in Radiation Oncology. 8(5). 101241–101241. 2 indexed citations
7.
Morris, Michael J., Steven P. Rowe, Michael A. Gorin, et al.. (2021). Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study. Clinical Cancer Research. 27(13). 3674–3682. 237 indexed citations breakdown →
8.
9.
Ng, Thomas S.C., Brian P. An, Steve Y. Cho, & Hyewon Hyun. (2020). US Trainee and Faculty Perspectives on Exposure to Nuclear Medicine/Molecular Imaging During Medical School. Current Problems in Diagnostic Radiology. 50(5). 585–591. 5 indexed citations
10.
McCarten, Kathleen M., Helen Nadel, Barry L. Shulkin, & Steve Y. Cho. (2019). Imaging for diagnosis, staging and response assessment of Hodgkin lymphoma and non-Hodgkin lymphoma. Pediatric Radiology. 49(11). 1545–1564. 81 indexed citations
11.
Ni, Dalong, Dawei Jiang, Christopher J. Kutyreff, et al.. (2018). Molybdenum-based nanoclusters act as antioxidants and ameliorate acute kidney injury in mice. Nature Communications. 9(1). 5421–5421. 259 indexed citations
12.
Jiang, Dawei, Hyung‐Jun Im, Haiyan Sun, et al.. (2017). Radiolabeled pertuzumab for imaging of human epidermal growth factor receptor 2 expression in ovarian cancer. European Journal of Nuclear Medicine and Molecular Imaging. 44(8). 1296–1305. 30 indexed citations
13.
Lee, Inki, Hyung‐Jun Im, Meiyappan Solaiyappan, & Steve Y. Cho. (2017). Comparison of novel multi-level Otsu (MO-PET) and conventional PET segmentation methods for measuring FDG metabolic tumor volume in patients with soft tissue sarcoma. EJNMMI Physics. 4(1). 22–22. 3 indexed citations
14.
Rowe, Steven P., Katarzyna J. Macura, Esther Mena, et al.. (2016). PSMA-Based [18F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer. Molecular Imaging and Biology. 18(3). 411–419. 199 indexed citations
15.
England, Christopher G., Hyung‐Jun Im, Liangzhu Feng, et al.. (2016). Re-assessing the enhanced permeability and retention effect in peripheral arterial disease using radiolabeled long circulating nanoparticles. Biomaterials. 100. 101–109. 58 indexed citations
16.
Rowe, Steven P., Curtiland Deville, Channing J. Paller, et al.. (2015). Uptake of [18F]DCFPyL in Paget's Disease of Bone, an Important Potential Pitfall in the Clinical Interpretation of PSMA PET Studies. Tomography. 1(2). 81–84. 26 indexed citations
17.
Szabó, Zsolt, Esther Mena, Steven P. Rowe, et al.. (2015). Initial Evaluation of [18F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer. Molecular Imaging and Biology. 17(4). 565–574. 354 indexed citations breakdown →
18.
Grudzinski, Joseph J., Kevin R. Kozak, William R. Clarke, et al.. (2014). A Phase 1 Study of 131I-CLR1404 in Patients with Relapsed or Refractory Advanced Solid Tumors: Dosimetry, Biodistribution, Pharmacokinetics, and Safety. PLoS ONE. 9(11). e111652–e111652. 25 indexed citations
19.
Cho, Steve Y., et al.. (2011). Congenital Agenesis of Right Parotid Gland Confounds MIBG Scan Interpretation in Craniocervical Neuroblastoma. Clinical Nuclear Medicine. 36(11). e162–e164. 7 indexed citations
20.
Zaheer, Atif, Steve Y. Cho, & Martin G. Pomper. (2009). New Agents and Techniques for Imaging Prostate Cancer. Journal of Nuclear Medicine. 50(9). 1387–1390. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by June-Key Chung Breakdown of academic impact, for papers by Andrei Iagaru Breakdown of academic impact, for papers by Katherine A. Vallis Breakdown of academic impact, for papers by Carsten Herskind Breakdown of academic impact, for papers by Jeffrey Y.C. Wong Breakdown of academic impact, for papers by James M. Larner Breakdown of academic impact, for papers by Margret Schottelius Breakdown of academic impact, for papers by Gerard W.M. Visser Breakdown of academic impact, for papers by Alan B. Packard Breakdown of academic impact, for papers by Tatsuo Ohira
Rankless by CCL
2026